Table 1 Clinical characteristics of patients with isolated API presenting with and without END
END (n = 47) | Non-END (n = 106) | P | |
|---|---|---|---|
Age, mean ± SD, year | 65.3 ± 11.9 | 68.1 ± 11.0 | 0.158 |
Female, sex, n (%) | 18 (38.3) | 44 (41.5) | 0.709 |
Hypertension, n (%) | 38 (80.9) | 78 (73.6) | 0.333 |
Diabetes, n (%) | 22 (46.8) | 36 (34.0) | 0.131 |
Smoking, n (%) | 12 (25.5) | 20 (18.9) | 0.350 |
Drinking, n (%) | 5 (10.6) | 17 (16.0) | 0.380 |
History of ischemic stroke, n (%) | 0 (0.0) | 2 (1.9) | 0.343 |
Blood pressure at admission | |||
SBP, mean ± SD, mmHg | 151.5 ± 19.9 | 152.2 ± 24.3 | 0.87 |
DBP, mean ± SD, mmHg | 82.7 ± 12.3 | 85.5 ± 13.9 | 0.234 |
Baseline blood glucose level, median (IQR), mmol/L | 7.2 6.2, 11.2) | 6.7 (5.5, 11.2) | 0.260 |
Arrival time, median (IQR), hours | 20.0 (7.0, 24.0) | 24.0 (10.0, 48.0) | 0.085 |
NIHSS score at admission, median, mean ± SD | 3.9 ± 2.1 | 3.9 ± 2.6 | 0.992 |
NIHSS score at discharge, median (IQR) | 4.9 ± 2.5 | 2.4 ± 2.0 | 0.000 |
Number of hospital days | 13.2 ± 3.1 | 11.8 ± 3.0 | 0.007 |
Laboratory tests | |||
Total cholesterol, mmol/l, mean ± SD | 4.7 ± 1.4 | 4.7 ± 1.3 | 0.958 |
Triglycerides, mmol/l, median (IQR) | 1.47 (1.05,2.12) | 1.60 (1.05, 2.31) | 0.826 |
HDL, mmol/l, median (IQR) | 1.11 (0.93, 1.26) | 1.18 (1.01, 1.36) | 0.062 |
LDL, mmol/l, mean ± SD | 2.9 ± 1.2 | 2.7 ± 1.0 | 0.490 |
Creatinine, mmol/l, mean ± SD | 66.6 ± 15.7 | 72.3 ± 23.3 | 0.08 |
AST, mmol/l, median (IQR) | 19.0 (15.0, 24.0) | 19.0 (15.0, 25.0) | 0.960 |
ALT, mmol/l, median (IQR) | 22.0 (17.0, 31.0) | 20.0 (16.0, 27.2) | 0.197 |
Treatment, n (%) 0.168 | |||
IVT + DAPT | 7 (14.9) | 6 (5.7) | |
DAPT | 32 (68.1) | 80 (75.5) | |
Anticoagulation | 8 (17.0) | 20 (18.9) | |